2016
DOI: 10.1007/s11427-016-5083-9
|View full text |Cite
|
Sign up to set email alerts
|

Alzheimer’s disease and gut microbiota

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
188
0
19

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 280 publications
(209 citation statements)
references
References 191 publications
1
188
0
19
Order By: Relevance
“…Evidence also suggests that these commensal species may control the development and function of immune cells throughout the body, including the microglia in the brain [88][89][90] . Therefore, the interaction between gut microbiota, neuroinflammation, and disease may be implicated as a peripheral influence for the pathogenesis of neurological disease [91][92][93] . While it is difficult to infer causality from available data, recent studies performing FMTs from clinical patient populations (e.g., depression, PD) to murine species provide compelling evidence as mice receiving FMTs from healthy humans remain healthy, while those who receiving FMTs from clinical patients begin to exhibit symptoms characteristic of the disease of the human FMT donor 75,94 .…”
Section: Gbmax: Linking the Gut And Neuroinflammationmentioning
confidence: 99%
See 1 more Smart Citation
“…Evidence also suggests that these commensal species may control the development and function of immune cells throughout the body, including the microglia in the brain [88][89][90] . Therefore, the interaction between gut microbiota, neuroinflammation, and disease may be implicated as a peripheral influence for the pathogenesis of neurological disease [91][92][93] . While it is difficult to infer causality from available data, recent studies performing FMTs from clinical patient populations (e.g., depression, PD) to murine species provide compelling evidence as mice receiving FMTs from healthy humans remain healthy, while those who receiving FMTs from clinical patients begin to exhibit symptoms characteristic of the disease of the human FMT donor 75,94 .…”
Section: Gbmax: Linking the Gut And Neuroinflammationmentioning
confidence: 99%
“…To this end, pre-clinical evidence indicates that serum LPS levels correlate with neurodegenerative pathology and neuronal cell death 35,91,[96][97][98] . This is further supported by clinical data as studies report that circulating levels of serum LPS strongly correlate with disease severity in AD, PD, and ALS patients 73,99 .…”
Section: Gbmax: Linking the Gut And Neuroinflammationmentioning
confidence: 99%
“…There is interplay between the several genetic and environmental reasons that can be correlated with the pathogenesis of AD but the deposition of extracellular β amyloid (Aβ) senile plaques (SP) and intracellular neurofibrallary tangles (NFT) has been recognized as the major factors for contributing the disease development [110] [111]. Recent research investigations emphasized the role of gut microbiome as the major environmental factor for affecting this dis- Moreover, the prominent role of indole-3-propionic acid (IPA) as a treatment modality for AD has been recently come into limelight.…”
Section: Alzheimer's Diseasesmentioning
confidence: 99%
“…Once infectious agents have been verified as the primordial etiological cues leading to AD, the more practical medications treating AD should at least include, for example, anti-infection agents such as minocycline (El-Shimy et al, 2015; Budni et al, 2016), anti-inflammation agents such as anhydroexfoliamycin (Leirós et al, 2015) or rapamycin (Siman et al, 2015), and anti-oxidation agents such as allicin (Zhu et al, 2015). With similar importance, modulation of gut microbiota from dysbiosis to homeostasis for the early-phase prophylaxis of AD through personalized diet and prebiotic/probiotic supplementation should also be addressed (Hu et al, 2016). …”
Section: Prospectivesmentioning
confidence: 99%